PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

NCT04142658 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

863

Enrollment

INDUSTRY

Sponsor class

Stopped Safety

Conditions

Aortic Valve Disease
Aortic Valve Stenosis
Aortic Valve Failure

Interventions

DRUG: Apixaban 5 MG
DRUG: Apixaban 2.5 MG
DRUG: Warfarin
DEVICE: On-X Aortic Mechanical Valve

Sponsor

Artivion Inc.

Collaborators

[object Object]